Similar articles

• New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.

  Boissier JR, Ratouis R, Dumont C, Derible PH, Lavaux JP. Boissier JR, et al. J Med Chem. 1970 Sep;13(5):971-3. doi: 10.1021/jm00299a041. J Med Chem. 1970. PMID: 4394057 No abstract available.
• Effect of ring substitution in 1-isopropylamino-3-phenoxypropan-2-ol on beta-adrenoceptor inhibition.

  Barrett AM, Wale JL. Barrett AM, et al. Eur J Pharmacol. 1970;12(3):372-4. doi: 10.1016/0014-2999(70)90091-9. Eur J Pharmacol. 1970. PMID: 4395558 No abstract available.
• A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.

  Moore GE, O'Donnell SR. Moore GE, et al. J Pharm Pharmacol. 1970 Mar;22(3):180-8. doi: 10.1111/j.2042-7158.1970.tb08494.x. J Pharm Pharmacol. 1970. PMID: 4399485 No abstract available.
• [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].

  Takenaka F, Takeya N. Takenaka F, et al. Nihon Rinsho. 1969 Oct;27(10):2470-8. Nihon Rinsho. 1969. PMID: 4390982 Review. Japanese. No abstract available.
• [Beta-receptor-blocking agents and their current clinical significance].

  Deptalla H, Wiegershausen B. Deptalla H, et al. Dtsch Gesundheitsw. 1968 Dec 12;23(50):2353-63. Dtsch Gesundheitsw. 1968. PMID: 4389656 Review. German. No abstract available.